AEVEX Prices 16M Shares at $20.00
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 13 hours ago
0mins
Should l Buy AVEX?
Drone maker AEVEX priced 16M shares at $20.00, within the expected $18.00-$21.00 range. Goldman Sachs, BofA and Jefferies acted as joint book running managers for the offering. The portfolio company of Madison Dearborn Partners' funds dubs itself "a global leader in cutting-edge unmanned systems."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVEX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVEX
Wall Street analysts forecast AVEX stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 20.000
Low
Averages
High
Current: 20.000
Low
Averages
High
No data
About AVEX
AEVEX Corp. is a defense technology prime contractor and critical enabler of the United States Unmanned Aerial Systems (UAS) dominance strategy missions. The Company delivers technology-leading products and solutions through two complementary business segments which are Tactical Systems and Global Solutions. The Tactical Systems designs and manufactures battle-tested, autonomous, modular, and attritable unmanned systems (UxS), including UAS and Unmanned Surface Vehicles (USV), along with other mission critical products. Global Solutions provides bespoke mission solutions, including artificial intelligence (AI)-enabled full-spectrum airborne ISR, counter-unmanned aerial systems (C-UAS), additive manufacturing, and specialized mission aircraft engineering, modification, and testing. Its solutions are primarily sold to agencies and organizations within the United States Department of War (DoW), Special Operations Forces (SOF), Intelligence Community (IC) and allied international partners.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aevex Raises $320 Million in IPO, Valued at $2.2 Billion
- Fundraising Success: Aevex successfully raised $320 million by offering 16 million shares at $20 each, within the $18 to $21 range, indicating strong market demand for its unmanned aircraft systems.
- Market Valuation: Following this financing, Aevex commands a fully diluted market value of $2.2 billion, reflecting investor confidence in its technological innovations and market potential, particularly in AI-enabled drone platforms.
- Product Applications: Aevex focuses on developing unmanned systems for surveillance, reconnaissance, and precision strikes, including loitering munitions designed to operate in complex or GPS-denied environments, highlighting the significance of its technology in modern warfare.
- Customer Base: The company primarily serves the US government, with 78% of projected 2025 revenue coming from government contracts, while also collaborating with allied partners, underscoring its strong influence and growth potential in the defense market.
See More
IPO Market Heats Up with $4.5 Billion Raised by Five Listings
- Record Fundraising: This week, five companies raised a total of $4.5 billion in IPOs, including two deals exceeding $1 billion, highlighting a significant uptick in market activity, particularly with Madison Air Solutions leading at $2.233 billion, reflecting strong demand for indoor air quality technologies.
- Strong Market Performance: Madison Air Solutions completed its IPO at the high end of pricing, achieving a market cap of $13.423 billion and a first-day return of 20%, indicating investor confidence in its air management technologies for data centers and commercial environments, which is expected to drive further market share growth.
- Biotech Breakthrough: Kailera Therapeutics raised $625 million, setting a record for US biotech IPOs with a market cap of $2.021 billion, as its lead candidate is currently in global Phase 3 trials, showcasing its potential in obesity treatment, with a first-day return of 63%.
- Growth in Defense Electronics: Arxis successfully raised $1.134 billion in its IPO, achieving a market cap of $11.633 billion; despite cyclical risks in aerospace and defense spending, its profitability and expanding free cash flow maintain its competitive edge, with a first-day return of 36%.
See More
Aevex's Strong IPO Performance with $320 Million Raised
- Delivery Milestone: Aevex disclosed in its SEC filing that it has delivered over 6,200 systems to date, showcasing its robust delivery capabilities in the drone market, which is expected to further drive revenue growth.
- Government Dependency: The filing indicates that Aevex derived 78% and 81% of its total sales from U.S. government and its agencies in fiscal years 2024 and 2025, highlighting the company's heavy reliance on government contracts, which may impact future revenue stability.
- IPO Performance: Aevex shares soared over 22% on their debut on the New York Stock Exchange, with the company's valuation skyrocketing to $2.7 billion, reflecting strong market confidence in its business model and growth potential.
- Funding Size: The company raised $320 million through the IPO by issuing 16 million shares of common stock, with underwriters having the option to purchase an additional 2.4 million shares within 30 days post-issue, further strengthening its capital base for future expansion.
See More
NYSE Issues Daily Pre-Market Advisory
- Market Advisory Issued: On April 17, 2026, the New York Stock Exchange released its daily pre-market advisory aimed at providing investors with insights before the market opens, assisting them in making informed trading decisions.
- IPO Celebration: Aevex (NYSE:AVEX) successfully debuted on the NYSE, marking a significant milestone in its initial public offering (IPO), which is expected to attract investor interest and enhance market activity.
- Listing Anniversary: Pinnacle West Capital (NYSE:PNW) celebrates its 65th anniversary of listing on the exchange, highlighting the company's stability in the capital markets and long-term growth potential, which may bolster investor confidence.
- Market Insights Access: Investors can download the NYSE TV app to access daily market dynamics and IPO activity information, further enhancing the effectiveness of their trading strategies.
See More
NYSE Daily Market Update Highlights Key Events
- Market Dynamics: Markets are up on Friday morning after President Trump indicated that the conflict in Iran “should be ending pretty soon,” reflecting investor optimism that could boost trading activity in the short term.
- IPO Launch: Aevex (NYSE: AVEX) successfully debuts on the NYSE, with CEO Roger Wells set to discuss the company's strategy on NYSE Live, which is expected to attract more investor interest and engagement.
- Stock Performance: Madison Air (NYSE: MAIR) saw its shares pop by over 17% on its first day of trading, indicating strong demand and investor confidence, which may pave the way for future fundraising activities.
- Industry Collaboration: Parker Institute of Cancer Immunotherapy CEO Karen Knudsen will elaborate on its collaboration with the Cancer Vaccine Coalition during NYSE Live, highlighting the potential for synergies and innovation within the industry.
See More
Aevex Announces IPO Terms to Raise $312 Million
- IPO Fundraising Plan: Aevex aims to raise $312 million by offering 16 million shares at a price range of $18 to $21, which will support the expansion of its unmanned aircraft systems and services.
- Market Positioning: The company focuses on developing unmanned and autonomous systems for defense applications, with 78% of its projected 2025 revenue coming from the US government, highlighting its strong reliance on the military market.
- Product Innovation: Aevex's offerings include loitering munitions and other unmanned systems designed to operate in complex or GPS-denied environments, supported by proprietary software for navigation and sensor integration, enhancing its competitiveness in the defense sector.
- Financial Performance: Aevex reported $433 million in revenue for the year ending December 31, 2025, indicating robust growth potential in the unmanned aircraft market, with plans to price its IPO on April 13, 2026.
See More
Aevex Raises $320 Million in IPO, Valued at $2.2 Billion
- Fundraising Success: Aevex successfully raised $320 million by offering 16 million shares at $20 each, within the $18 to $21 range, indicating strong market demand for its unmanned aircraft systems.
- Market Valuation: Following this financing, Aevex commands a fully diluted market value of $2.2 billion, reflecting investor confidence in its technological innovations and market potential, particularly in AI-enabled drone platforms.
- Product Applications: Aevex focuses on developing unmanned systems for surveillance, reconnaissance, and precision strikes, including loitering munitions designed to operate in complex or GPS-denied environments, highlighting the significance of its technology in modern warfare.
- Customer Base: The company primarily serves the US government, with 78% of projected 2025 revenue coming from government contracts, while also collaborating with allied partners, underscoring its strong influence and growth potential in the defense market.
See More
IPO Market Heats Up with $4.5 Billion Raised by Five Listings
- Record Fundraising: This week, five companies raised a total of $4.5 billion in IPOs, including two deals exceeding $1 billion, highlighting a significant uptick in market activity, particularly with Madison Air Solutions leading at $2.233 billion, reflecting strong demand for indoor air quality technologies.
- Strong Market Performance: Madison Air Solutions completed its IPO at the high end of pricing, achieving a market cap of $13.423 billion and a first-day return of 20%, indicating investor confidence in its air management technologies for data centers and commercial environments, which is expected to drive further market share growth.
- Biotech Breakthrough: Kailera Therapeutics raised $625 million, setting a record for US biotech IPOs with a market cap of $2.021 billion, as its lead candidate is currently in global Phase 3 trials, showcasing its potential in obesity treatment, with a first-day return of 63%.
- Growth in Defense Electronics: Arxis successfully raised $1.134 billion in its IPO, achieving a market cap of $11.633 billion; despite cyclical risks in aerospace and defense spending, its profitability and expanding free cash flow maintain its competitive edge, with a first-day return of 36%.
See More
Aevex's Strong IPO Performance with $320 Million Raised
- Delivery Milestone: Aevex disclosed in its SEC filing that it has delivered over 6,200 systems to date, showcasing its robust delivery capabilities in the drone market, which is expected to further drive revenue growth.
- Government Dependency: The filing indicates that Aevex derived 78% and 81% of its total sales from U.S. government and its agencies in fiscal years 2024 and 2025, highlighting the company's heavy reliance on government contracts, which may impact future revenue stability.
- IPO Performance: Aevex shares soared over 22% on their debut on the New York Stock Exchange, with the company's valuation skyrocketing to $2.7 billion, reflecting strong market confidence in its business model and growth potential.
- Funding Size: The company raised $320 million through the IPO by issuing 16 million shares of common stock, with underwriters having the option to purchase an additional 2.4 million shares within 30 days post-issue, further strengthening its capital base for future expansion.
See More
NYSE Issues Daily Pre-Market Advisory
- Market Advisory Issued: On April 17, 2026, the New York Stock Exchange released its daily pre-market advisory aimed at providing investors with insights before the market opens, assisting them in making informed trading decisions.
- IPO Celebration: Aevex (NYSE:AVEX) successfully debuted on the NYSE, marking a significant milestone in its initial public offering (IPO), which is expected to attract investor interest and enhance market activity.
- Listing Anniversary: Pinnacle West Capital (NYSE:PNW) celebrates its 65th anniversary of listing on the exchange, highlighting the company's stability in the capital markets and long-term growth potential, which may bolster investor confidence.
- Market Insights Access: Investors can download the NYSE TV app to access daily market dynamics and IPO activity information, further enhancing the effectiveness of their trading strategies.
See More
NYSE Daily Market Update Highlights Key Events
- Market Dynamics: Markets are up on Friday morning after President Trump indicated that the conflict in Iran “should be ending pretty soon,” reflecting investor optimism that could boost trading activity in the short term.
- IPO Launch: Aevex (NYSE: AVEX) successfully debuts on the NYSE, with CEO Roger Wells set to discuss the company's strategy on NYSE Live, which is expected to attract more investor interest and engagement.
- Stock Performance: Madison Air (NYSE: MAIR) saw its shares pop by over 17% on its first day of trading, indicating strong demand and investor confidence, which may pave the way for future fundraising activities.
- Industry Collaboration: Parker Institute of Cancer Immunotherapy CEO Karen Knudsen will elaborate on its collaboration with the Cancer Vaccine Coalition during NYSE Live, highlighting the potential for synergies and innovation within the industry.
See More
Aevex Announces IPO Terms to Raise $312 Million
- IPO Fundraising Plan: Aevex aims to raise $312 million by offering 16 million shares at a price range of $18 to $21, which will support the expansion of its unmanned aircraft systems and services.
- Market Positioning: The company focuses on developing unmanned and autonomous systems for defense applications, with 78% of its projected 2025 revenue coming from the US government, highlighting its strong reliance on the military market.
- Product Innovation: Aevex's offerings include loitering munitions and other unmanned systems designed to operate in complex or GPS-denied environments, supported by proprietary software for navigation and sensor integration, enhancing its competitiveness in the defense sector.
- Financial Performance: Aevex reported $433 million in revenue for the year ending December 31, 2025, indicating robust growth potential in the unmanned aircraft market, with plans to price its IPO on April 13, 2026.
See More
